Hyperpolarized 129Xe Imaging of Pulmonary Gas Exchange

肺部气体交换的超极化 129Xe 成像

基本信息

  • 批准号:
    7456608
  • 负责人:
  • 金额:
    $ 22.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-07-01 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Our global aim is to develop a robust pulmonary gas exchange imaging method using hyperpolarized 129Xe MRI, which can be used clinically and in small animal research of pulmonary diseases involving gas exchange abnormalities. We propose to significantly improve the resolution and accuracy of our recently demonstrated 129Xe gas exchange imaging method, test its detection limits, compare the method to its most likely competition - high-resolution CT, and compare it to the gold standard - histology. A noninvasive and effective biomarker could lead to a dramatic change in our ability to diagnose, treat, and understand interstitial lung diseases. This research will be carried out in rats and lays the groundwork for anticipated clinical translation. Our method uses hyperpolarized 129Xe to differentially image 129Xe uptake into pulmonary blood/gas barrier and red blood cells. Hyperpolarization increases the 129Xe MRI signal by 5 orders of magnitude compared to thermal polarization, making high resolution gas imaging possible. The large 129Xe chemical shift enables us to discriminate 129Xe in airspace, blood/gas barrier, and red blood cell compartments. For 129Xe to reach the red blood cells, it must first traverse the blood/gas barrier. Since diffusive transport times scale as the square of barrier thickness, imaging of 129Xe uptake in red blood cells is exquisitely sensitive and capable of detecting 5¿m changes in barrier thickness. Until now, direct imaging of the gas exchange process has not been possible by any method. In addition to ventilation and perfusion, gas exchange is the most fundamental aspect of lung function. Impairment of pulmonary gas exchange occurs in numerous pathologies, but is difficult to assess definitively at early stages when intervention is most likely to be effective. Diseases such as pulmonary fibrosis, inflammation, and radiation induced pneumonitis initially may not dramatically change ventilation or perfusion. Only once the disease is very advanced, can significant structural abnormalities be diagnosed via density increases noted on high-resolution CT. The proposed work will add a fundamental and sensitive new capability to pulmonary disease imaging. Completion of the proposed work will ensure that this method will be ready for translation to a clinical setting, and to the routine application in longitudinal evaluation animal models of pulmonary disease. The proposed work will develop a novel and non-invasive method for imaging pulmonary gas exchange abnormalities. It is particularly relevant for the early diagnosis of interstitial lung diseases such as pulmonary fibrosis. Upon completion of the project, the method should be ready for translation to a clinical setting.
描述(申请人提供):我们的全球目标是开发一种使用超极化129Xe MRI的强大的肺气体交换成像方法,该方法可用于临床和涉及气体交换异常的肺部疾病的小动物研究。我们建议显著提高我们最近展示的129Xe气体交换成像方法的分辨率和准确性,测试其检测极限,将该方法与其最有可能的竞争对手-高分辨率CT进行比较,并将其与金标准-组织学进行比较。一种非侵入性和有效的生物标志物可能会导致我们诊断、治疗和了解间质性肺疾病的能力发生巨大变化。这项研究将在大鼠身上进行,并为预期的临床移植奠定基础。我们的方法使用超极化的129Xe来差示摄取肺血/气屏障和红细胞的129Xe。与热极化相比,超极化使129Xe磁共振信号增加了5个数量级,使高分辨率气体成像成为可能。大的129Xe化学位移使我们能够区分空域、血/气屏障和红血球隔间中的129Xe。要让129Xe到达红细胞,它必须首先穿过血/气屏障。由于扩散传输时间是屏障厚度的平方,因此红细胞摄取~(129)Xe的成像非常灵敏,能够检测屏障厚度的5?m变化。到目前为止,任何方法都不可能直接对气体交换过程进行成像。除了呼吸和灌流,气体交换是肺功能最基本的方面。肺气体交换障碍可见于多种病理情况,但在干预最有可能有效的早期阶段很难明确评估。肺纤维化、炎症和放射性肺炎等疾病最初可能不会显著改变呼吸或血流灌注。只有当疾病非常严重时,才能通过高分辨率CT上记录的密度增加来诊断显著的结构异常。这项拟议的工作将为肺部疾病成像增加一种基本和敏感的新能力。拟议工作的完成将确保该方法将准备好转换到临床环境中,并在肺部疾病动物模型的纵向评估中常规应用。这项拟议的工作将开发一种新的、非侵入性的肺气体交换异常成像方法。它与肺纤维化等间质性肺疾病的早期诊断尤其相关。在该项目完成后,该方法应准备好转化为临床环境。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bastiaan Driehuys其他文献

Bastiaan Driehuys的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bastiaan Driehuys', 18)}}的其他基金

Xenon MRI in Pulmonary Hypertension
氙 MRI 在肺动脉高压中的应用
  • 批准号:
    10670092
  • 财政年份:
    2021
  • 资助金额:
    $ 22.95万
  • 项目类别:
Xenon MRI in Pulmonary Hypertension
氙 MRI 在肺动脉高压中的应用
  • 批准号:
    10415160
  • 财政年份:
    2021
  • 资助金额:
    $ 22.95万
  • 项目类别:
Xenon MRI in Pulmonary Hypertension
氙 MRI 在肺动脉高压中的应用
  • 批准号:
    10204681
  • 财政年份:
    2021
  • 资助金额:
    $ 22.95万
  • 项目类别:
Using MRI To Visualize Regional Therapy Response In Idiopathic Pulmonary Fibrosis
使用 MRI 可视化特发性肺纤维化的局部治疗反应
  • 批准号:
    9064201
  • 财政年份:
    2015
  • 资助金额:
    $ 22.95万
  • 项目类别:
Using MRI To Visualize Regional Therapy Response In Idiopathic Pulmonary Fibrosis
使用 MRI 可视化特发性肺纤维化的局部治疗反应
  • 批准号:
    10390384
  • 财政年份:
    2015
  • 资助金额:
    $ 22.95万
  • 项目类别:
Using MRI To Visualize Regional Therapy Response In Idiopathic Pulmonary Fibrosis
使用 MRI 可视化特发性肺纤维化的局部治疗反应
  • 批准号:
    10211015
  • 财政年份:
    2015
  • 资助金额:
    $ 22.95万
  • 项目类别:
Using MRI To Visualize Regional Therapy Response In Idiopathic Pulmonary Fibrosis
使用 MRI 可视化特发性肺纤维化的局部治疗反应
  • 批准号:
    10593048
  • 财政年份:
    2015
  • 资助金额:
    $ 22.95万
  • 项目类别:
3D RADIAL PIPELINE FOR RECONSTRUCTION OF CLINICAL 129XE IMAGES
用于重建临床 129XE 图像的 3D 径向管道
  • 批准号:
    8363198
  • 财政年份:
    2011
  • 资助金额:
    $ 22.95万
  • 项目类别:
Early Detection of Changes in Pulmonary Gas Exchange by Hyperpolarized Xe MRI
通过超极化 Xe MRI 早期检测肺部气体交换的变化
  • 批准号:
    8214524
  • 财政年份:
    2011
  • 资助金额:
    $ 22.95万
  • 项目类别:
Early Detection of Changes in Pulmonary Gas Exchange by Hyperpolarized Xe MRI
通过超极化 Xe MRI 早期检测肺部气体交换的变化
  • 批准号:
    8025083
  • 财政年份:
    2011
  • 资助金额:
    $ 22.95万
  • 项目类别:

相似海外基金

Gain-of-function toxicity in alpha-1 antitrypsin deficient type 2 alveolar epithelial cells
α-1 抗胰蛋白酶缺陷型 2 型肺泡上皮细胞的功能获得毒性
  • 批准号:
    10751760
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
The role of alveolar macrophages and regulatory pathways in post-transplant lung inflammation.
肺泡巨噬细胞和调节途径在移植后肺部炎症中的作用。
  • 批准号:
    23K08315
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanical signaling through the nuclear membrane in lung alveolar health
通过核膜的机械信号传导影响肺泡健康
  • 批准号:
    10677169
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
Mechanistic studies of the genetic contribution of desmoplakin to pulmonary fibrosis in alveolar type 2 cells
桥粒斑蛋白对肺泡2型细胞肺纤维化的遗传贡献机制研究
  • 批准号:
    10736228
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
Pilot Studies of PAX3-FOXO1 Fusions Proteins in Alveolar Rhabdomyosarcoma
PAX3-FOXO1 融合蛋白在肺泡横纹肌肉瘤中的初步研究
  • 批准号:
    10726763
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndrome
肝肺综合征低氧血症的新肺泡机制
  • 批准号:
    10718446
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
Utilizing induced pluripotent stem cells to study the role of alveolar type 2 cell dysfunction in pulmonary fibrosis
利用诱导多能干细胞研究肺泡2型细胞功能障碍在肺纤维化中的作用
  • 批准号:
    10591174
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
Injury of blood brain and alveolar-endothelial barriers caused by alcohol and electronic cigarettes via purinergic receptor signaling
酒精和电子烟通过嘌呤受体信号传导引起血脑和肺泡内皮屏障损伤
  • 批准号:
    10638221
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
Alveolar Epithelial Cell Dysfunction Induced By Flavored E-Cigarette Aerosols
加味电子烟气雾剂引起的肺泡上皮细胞功能障碍
  • 批准号:
    10770080
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
Delineating the role of let-7 microRNA on lung AT2 cell homeostasis, alveolar regeneration, and interstitial lung disease
描述let-7 microRNA对肺AT2细胞稳态、肺泡再生和间质性肺疾病的作用
  • 批准号:
    10634881
  • 财政年份:
    2023
  • 资助金额:
    $ 22.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了